Hyundai Motor India Ltd

Hyundai Motor India Ltd rose 1.21% today to trade at Rs 2475. The BSE Auto index is up 0.4% to quote at 56661.14. The index is up 6.73 % over last one month. Among the other constituents of the index, TVS Motor Company Ltd increased 1.12% and Samvardhana Motherson International Ltd added 0.66% on the day. The BSE Auto index went down 3.47 % over last one year compared to the 2.59% fall in benchmark SENSEX. Hyundai Motor India Ltd has added 18.71% over last one month compared to 6.73% gain in BSE Auto index and 1.81% drop in the SENSEX. On the BSE, 1496 shares were traded in the counter so far compared with average daily volumes of 67229 shares in the past one month. The stock hit a record high of Rs 2624.3 on 19 Aug 2025. The stock hit a 52-week low of Rs 1542.95 on 07 Apr 2025.Powered by Capital Market - Live

The stock had surged 15.5% in the past two sessions, taking its one-month gains to 18.2% and three-month gains to 33.1%. It touched a record high of Rs 2,624.30 on 19 August 2025. Last week, a foreign brokerage initiated coverage with a 'Buy' rating and a target price of Rs 2,600, citing Hyundai's strong product pipeline, planned capacity expansion, and supportive macroeconomic trends. The brokerage said the company's 'strategic catch-up' plan, including new launches and ramped-up production, would help it capture additional market share in the years ahead. Hyundai Motor India manufactures and sells passenger cars, along with vehicle parts and accessories. On the earnings front, consolidated net profit fell 8.1% year-on-year to Rs 1,369.23 crore in Q1 FY26, while net sales declined 5.6% to Rs 16,179.62 crore. Powered by Capital Market - Live

The brokerage said Hyundai is well-positioned to tap into a key stress point in the auto industry, backed by a strong product cycle, planned manufacturing capacity expansion, and supportive macroeconomic conditions. It added that Hyundai is poised to launch new products and capture additional market share as it ramps up output. This strategic catch-up plan is expected to provide a significant boost to the company's growth in the coming years. Hyundai Motor India is engaged in the manufacturing and sale of passenger cars, along with the sale of motor vehicle parts and accessories. On a consolidated basis, net profit of Hyundai Motor India declined 8.08% to Rs 1369.23 crore while net sales declined 5.55% to Rs 16179.62 crore in Q1 June 2025 over Q1 June 2024. Powered by Capital Market - Live

Hyundai Motor India (HMIL) has achieved total monthly sales of 60,073 units (domestic: 43,973 units + exports: 16,100 units), in July 2025. Commenting on HMIL sales, Tarun Garg, Whole-time Director and Chief Operating Officer, HMIL said, 'As we celebrate the incredible 10-year journey of Hyundai CRETA in India, we are proud to see it setting new benchmarks in comfort, convenience and performance thereby holding on to the best-selling SUV crown in the Mid-SUV segment, every completed year since its launch in 2015. In the January-July 2025 period too, Hyundai CRETA has further fortified its leadership position amongst SUVs. While the overall auto industry has seen some softness in recent months, we remain optimistic with the onset of the festive season and are fully geared up with robust supply and exciting product offerings. At HMIL, we continue to stay focused on delivering enhanced value and innovation to our customers and with the upcoming state of the art facility at Talegaon, we are well positioned to adapt to market movements.' Powered by Capital Market - Live

Hyundai Motor India announced that the 29th Annual General Meeting(AGM) of the company will be held on 28 August 2025.Powered by Capital Market - Live

Hyundai Motor India has fixed 05 August 2025 as record date for payment of final dividend of Rs 21 per equity share. Powered by Capital Market - Live

Net profit of Hyundai Motor India declined 8.08% to Rs 1369.23 crore in the quarter ended June 2025 as against Rs 1489.65 crore during the previous quarter ended June 2024. Sales declined 5.55% to Rs 16179.62 crore in the quarter ended June 2025 as against Rs 17131.25 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales16179.6217131.25 -6 OPM %13.5113.66 - PBDT2375.302532.36 -6 PBT1847.202003.38 -8 NP1369.231489.65 -8 Powered by Capital Market - Live

Hyundai Motor India will hold a meeting of the Board of Directors of the Company on 30 July 2025.Powered by Capital Market - Live

Securities in F&O Ban: RBL Bank shares are banned from F&O trading on 2 July 2025. Stocks to Watch: Hyundai Motor India has achieved total monthly sales of 60,924 units in June 2025. SUVs contributed 67.6% to HMIL total domestic sales in June 2025. Also, the total sales for the April-June quarter FY2026 were reported at 1,80,399 units. Maruti Suzuki India's total sales declined 6.27% to 167,993 units in June 2025 as against 179,228 units sold in June 2024. Total production fell 4.17% to 127,545 units in June 2025 compared with 133,095 units in June 2024. V-mart Retail's revenue from operations stood at Rs 885 crore in Q1 FY26, up 13% compared with Rs 786 crore in Q1 FY25. The same store sales growth (SSSG) stood at 1% in Q1 FY26. JSW Energy's step-down subsidiary, JSW Renew Energy Thirty Seven, has signed battery energy storage purchase agreements (BESPA) with Rajasthan Rajya Vidyut Utpadan Nigam for 250 MW / 500 MWh standalone battery energy storage system (BESS). The BESPA is signed for a duration of 12 years, with a tariff of Rs 2,24,000 per MW per month Lloyds Metals & Energy announced that iron ore production remained stable at around 4.0 million tonnes, maintaining last year's robust levels. Direct reduced iron (DRI) production rose 3% to 79,033 tonnes in Q1 FY26. Ceigall India's subsidiary, Ceigall Northern Ayodhya Bypass has received construction order worth Rs 1,199.30 crore from National Highways Authority of India (NHAI) on hybrid annuity mode. AstraZeneca Pharma India has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab Solution for infusion 120 mg/2.4 ml and 500 mg/10 ml (Brand name: Imfinzi) for an additional indication.Powered by Capital Market - Live

Hyundai Motor India has achieved total monthly sales of 60,924 units (domestic: 44,024 units + exports: 16,900 units) in June 2025. Also, the total sales for the Apr-Jun quarter FY2026 were reported at 1,80,399 units (domestic: 1,32,259 units + exports: 48,140 units). With the increased focus on exports, HMIL's export contribution reached 26.7% to its total sales in Q1 of FY2026. Powered by Capital Market - Live